Insulin Pens, Syringes, Pumps And Injectors Market Size and Forecast 2024-2033| Novo Nordisk A/S, Eli Lilly and Company, Medtronic PLC, Abbott Laboratories, Insulet Corporation,

Overview and Scope

Insulin pens, syringes, pumps, and injectors are used to administer insulin to diabetic patients to control blood glucose levels. These devices are reusable or disposable tools used to inject the desired dose of insulin into the blood of a diabetic patient.

Sizing and Forecast

The insulin pens, syringes, pumps and injectors market size has grown strongly in recent years. It will grow from <b>$23.3 billion in 2023 to $25.36 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. </b> The growth in the historic period can be attributed to rising diabetes prevalence, advancements in insulin delivery, patient preference for convenience, aging population.

The insulin pens, syringes, pumps and injectors market size is expected to see strong growth in the next few years. It will grow to <b>$34.41 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. </b> The growth in the forecast period can be attributed to emerging markets growth, regulatory support and reimbursement, personalized medicine, value-based healthcare. Major trends in the forecast period include artificial intelligence (ai) integration, handheld and wireless ultrasound devices, 3d/4d imaging, fusion imaging.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Segmentation & Regional Insights

The insulin pens, syringes, pumps and injectors market covered in this report is segmented –

1) By Type: Pens, Injectors And Pumps, Syringes

2) By Pens: Reusable, Disposable

3) By Pumps: Tubed Pumps, Tubeless Pumps

4) By End Users: Hospitals, Homecare, Other End Users

<b>North America</b> was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. <b>Asia-Pacific</b> was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

Major Driver Impacting Market Growth

An increase in the prevalence of diabetes globally is driving the growth of the insulin pens, syringes, pumps, and injectors market. The increase in the number of people suffering from obesity, unhealthy eating habits, physical inactivity, and the increasing geriatric population are some of the key factors which are leading to the increase in the global prevalence of diabetes. According to the US Centers for Disease Control and Prevention (CDC) in 2020, around 34.2 million people in the U.S. were suffering from diabetes. Also, according to the International Diabetes Federation, in 2021, globally approximately537 million adults were living with diabetes; by 2045, this number would rise to 783 million. Therefore, the increase in the prevalence of diabetes globally is driving the growth of the insulin pens, syringes, pumps, and injectors market.

Key Industry Players

Major companies operating in the insulin pens, syringes, pumps and injectors market include <b> Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd. </b>

The insulin pens, syringes, pumps and injectors market report table of contents includes:

1. Executive Summary

2. Insulin Pens, Syringes, Pumps And Injectors Market Characteristics

3. Insulin Pens, Syringes, Pumps And Injectors Market Trends And Strategies

4. Insulin Pens, Syringes, Pumps And Injectors Market – Macro Economic Scenario

5. Global Insulin Pens, Syringes, Pumps And Injectors Market Size and Growth

.

.

.

26. South America Insulin Pens, Syringes, Pumps And Injectors Market

27. Brazil Insulin Pens, Syringes, Pumps And Injectors Market

28. Middle East Insulin Pens, Syringes, Pumps And Injectors Market

29. Africa Insulin Pens, Syringes, Pumps And Injectors Market

30. Insulin Pens, Syringes, Pumps And Injectors Market Competitive Landscape And Company Profiles

Top Major Players:

• Novo Nordisk A/S
• Eli Lilly and Company
• Medtronic PLC
• Abbott Laboratories
• Insulet Corporation

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model